FR2429591A1 - CANCER TREATMENT METHOD AND COMPOSITION - Google Patents

CANCER TREATMENT METHOD AND COMPOSITION

Info

Publication number
FR2429591A1
FR2429591A1 FR7819704A FR7819704A FR2429591A1 FR 2429591 A1 FR2429591 A1 FR 2429591A1 FR 7819704 A FR7819704 A FR 7819704A FR 7819704 A FR7819704 A FR 7819704A FR 2429591 A1 FR2429591 A1 FR 2429591A1
Authority
FR
France
Prior art keywords
composition
particles
cancer
treatment method
cancer treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7819704A
Other languages
French (fr)
Other versions
FR2429591B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2429591A1 publication Critical patent/FR2429591A1/en
Application granted granted Critical
Publication of FR2429591B1 publication Critical patent/FR2429591B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention se rapporte à un procédé et à une composition de traitement du cancer. Elle est caractérisée en ce qu'on introduit à l'intérieur des cellules de tissus vivants de petites particules ayant des propriétés ferromagnétiques, paramagnétiques ou diamagnétiques, et en ce qu'on assure leur chauffage inductif en les soumettant à un champ électromagnétique alternatif de haute fréquence, une amélioration de la sélectivité et de l'affinité des cellules cancéreuses pour les particules pouvant être obtenue par incorporation de radioisotopes ou d'anticorps spécifiques auxdites particules. L'invention se rapporte au traitement du cancer.The invention relates to a method and composition for treating cancer. It is characterized in that small particles having ferromagnetic, paramagnetic or diamagnetic properties are introduced inside the cells of living tissues, and in that their inductive heating is ensured by subjecting them to an alternating electromagnetic field of high frequency, an improvement in the selectivity and the affinity of the cancer cells for the particles which can be obtained by incorporating radioisotopes or antibodies specific to said particles. The invention relates to the treatment of cancer.

FR7819704A 1978-06-30 1978-06-30 CANCER TREATMENT METHOD AND COMPOSITION Granted FR2429591A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828941 DE2828941A1 (en) 1978-06-30 1978-06-30 CANCER TREATMENT AGENTS

Publications (2)

Publication Number Publication Date
FR2429591A1 true FR2429591A1 (en) 1980-01-25
FR2429591B1 FR2429591B1 (en) 1981-06-26

Family

ID=6043278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7819704A Granted FR2429591A1 (en) 1978-06-30 1978-06-30 CANCER TREATMENT METHOD AND COMPOSITION

Country Status (3)

Country Link
DE (1) DE2828941A1 (en)
FR (1) FR2429591A1 (en)
GB (1) GB2024007B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508802A1 (en) * 1981-07-03 1983-01-07 Thomson Csf Magnetic powders for use in hyperthermic treatments - e.g. of tumours, heated by hysteresis in alternating magnetic field

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
DE3709851A1 (en) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te NMR DIAGNOSTIC LIQUID COMPOSITIONS
DE4419256A1 (en) * 1994-06-01 1995-12-07 Rau Freiherr Von Nagell Helmut Intravenous admin of iron
WO1999051278A1 (en) * 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company Inorganic material for radioactive drug delivery
US11076916B2 (en) 2015-12-23 2021-08-03 Rhode Island Hospital Thermal accelerant compositions and methods of use
EP3393383A4 (en) 2015-12-23 2019-07-31 Rhode Island Hospital Thermal accelerant compositions and methods of use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
FR2316974A1 (en) * 1975-07-11 1977-02-04 Leveen Harry PROCESS FOR TREATMENT OF TUMORS BY DIATHERMIA
FR2321305A1 (en) * 1975-08-04 1977-03-18 Critical Systems METHOD AND APPARATUS FOR HEATING TISSUES, IN PARTICULAR FOR TREATMENT OF TUMORS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294686A (en) * 1966-12-27 Pigment particles coated with organo-alumtnum compounds
DE1284528B (en) * 1967-03-08 1968-12-05 Foerster Device for the elimination of biological tissue by inductively heated bodies with temperature stabilizing properties
DE1692771A1 (en) * 1968-02-24 1972-01-05 Willy Dr Med Seuss Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them
SE372421B (en) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
GB1270410A (en) * 1969-09-25 1972-04-12 Allor Corp Colloidal composition and method of preparing the same
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
SE431214B (en) * 1977-06-02 1984-01-23 Klaus H Mosbach SET TO MAKE MAGNETIC POLYMER PARTICLES BASED ON A PREFERRED BIOLOGY ACTIVE SUBSTANCE

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
FR2316974A1 (en) * 1975-07-11 1977-02-04 Leveen Harry PROCESS FOR TREATMENT OF TUMORS BY DIATHERMIA
FR2321305A1 (en) * 1975-08-04 1977-03-18 Critical Systems METHOD AND APPARATUS FOR HEATING TISSUES, IN PARTICULAR FOR TREATMENT OF TUMORS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1974 *
NV8021/67 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508802A1 (en) * 1981-07-03 1983-01-07 Thomson Csf Magnetic powders for use in hyperthermic treatments - e.g. of tumours, heated by hysteresis in alternating magnetic field

Also Published As

Publication number Publication date
GB2024007B (en) 1983-04-27
GB2024007A (en) 1980-01-09
DE2828941A1 (en) 1980-01-10
FR2429591B1 (en) 1981-06-26
DE2828941C2 (en) 1989-03-16

Similar Documents

Publication Publication Date Title
Lasne et al. Two-stage malignant transformation of rat fibroblasts in tissue culture
FR2429591A1 (en) CANCER TREATMENT METHOD AND COMPOSITION
Jordan et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro
US20120149029A1 (en) Magnetic Needle Biopsy
Shintaku et al. Identification of oncocytic lesions of salivary glands by anti‐mitochondrial immunohistochemistry
FR2437837A1 (en) PROCESS FOR THE PREPARATION OF AN ALLERGEN TREATED WITH AN ALDEHYDE, PRODUCT OBTAINED AND ITS THERAPEUTIC APPLICATION
US7309316B1 (en) Magnetic needle biopsy
Zupancic Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma
FR2404289B1 (en) FERROMAGNETIC METAL PARTICLES ESSENTIALLY COMPOSED OF IRON, AND PROCESS FOR THEIR PREPARATION
BE855833A (en) PROCESS FOR THE TREATMENT OF STEEL WITH ORIENTAL SILICON AND STEEL THUS OBTAINED
FR2391733A1 (en) ANTIGEN AGAINST TUMORS AND PREPARATION METHOD THEREOF
BR112022016715A2 (en) VIRAL VECTORS THAT EXPRESS THERAPEUTIC PROTEINS SPECIFICALLY IN MYELOID CELLS AND MICROGLIA
Imam et al. Immunohistochemical study of the expression of human milk fat globule membrane glycoprotein 70
Garin-Chesa et al. Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
DE3686811D1 (en) METHOD AND COMPOSITION FOR TREATING CANCER AND NON-MALIGNAL TUMORS.
ES467231A1 (en) Method of treating molten metal
Karewicz et al. Surface-modified SPION systems for cancer therapy
Kotkas et al. Autologous mesenchymal stem cells in treatment of liver cirrhosis: evaluation of effectiveness and visualization method
FR1001557A (en) Process and apparatus for the treatment of phosphate materials, in particular for the manufacture of fertilizers
SU96727A1 (en) The method of diffusion saturation of the surface layers of metal products
SU671848A1 (en) Magnetic-hydrostatic separator
FR919857A (en) Process for treating metal parts for any coating operation and in particular for enamelling
GB737098A (en) Improvements in or relating to travelling wave linear particle accelerators
CN112426536B (en) Magnetic targeting Fe3O4Nano-composite and preparation method and application thereof
SU116147A1 (en) The method of grinding and electrification of synthetic magnetite particles

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse